Analytik Jena Announces Financial Figures for the First Quarter 2011/2012

• Revenue and EBIT in line with expectations
• Net profit and EPS increased by 3.7 % or by 13.6 %
• Operating cashflow up 33.4 % year-on-year

Jena (Germany), February 14, 2012 — Analytik Jena AG (Prime Standard: AJA, ISIN: DE0005213508) has made a good start into the financial year 2011/2012. After three months consolidated revenue of EUR 23.2 m (previous year: EUR 23.7 m) was achieved and remained largely stable year-on-year. Overall, the Group generated a net profit for the period of EUR 1.5 m. Earnings per share were EUR 0.25 (previous year: EUR 0.22).

"We are satisfied with the results achieved in the first quarter. Overall, we are in line with our expectations. Both regarding revenue and earnings, without large-scale orders we were successfull to build on a strong quarter last year", said Klaus Berka, CEO of Analytik Jena AG. "We expect to reach and to exceed previous-year level already in the second quarter."

Revenue Development and Segments

In what is by far the most important export market for Analytik Jena, sales in Asia again rose in double digits, by 15.4 %. Over here, the Group generated overall revenue of EUR 7.8 m (previous year: EUR 6.8 m). In the America sales region revenue totaled EUR 2.0 m (previous year: EUR 1.6 m). On its home market, Analytik Jena posted sales of EUR 6.9 m (previous year: EUR 8.1 m) and in Europe EUR 5.8 m (previous year: EUR 6.6 m). After three months, due to the regional shift of sales to Asia, the export ratio was 70.1 % (previous year: 66.0 %).

The biggest segment, Analytical Instrumentation was down only 2.7 % year-on-year with sales of EUR 14.1 m. Analytik Jena anticipates the segment will compensate for the decline in sales in the third quarter and on a whole-year basis again exceed the previous-year sales level.

Despite good end-of-year business in 2011, in the first quarter of 2011/2012 Life Science sales also declined slightly year-on-year, by 0.9 %. This is due particularly to declining sales at CyBio AG (consolidated in this segment) not reaching the strong level of the previous year. After three months, revenue in Life Science segment totaled EUR 7.9 m (previous year: EUR 8.0 m).

In the reporting period, in the Optics consumer segment Analytik Jena generated EUR 1.1 m (previous year: EUR 1.2 m), 7.7 % less than in the previous year. In the second quarter, the segment will again be able to grow through the extension of the service portfolio as OEM vendor. Analytik Jena was successful in acquiring an additional order volume of EUR 1.1 m for special optical products and components.

Earnings

After three months in the current financial year the Group posted net profit for the period of EUR 1.5 m (previous year: EUR 1.4 m). That corresponds to an increase of 3.7 % compared to last year's period. Earnings per share were at EUR 0.25 (previous year: EUR 0.22). The Company benefited especially from the development of the USD at the end of the quarter. Correspondingly, the financial result and EBT developed positively. The Group posted total EBT of EUR 2.1 m (previous year: EUR 2.0 m), an upturn of 3.7 %. EBITDA fell by 9.1 % to EUR 2.9 m (previous year: EUR 3.2 m). In the past quarter, the Group posted an operating profit (EBIT) of EUR 1.9 m (previous year: EUR 2.2 m), 15.9 % down year-on-year. The Company achieved an EBIT margin of 8.2 % compared with 9.5 % in the same quarter of the previous year.

Changes in Statement of Financial Position

The Group’s total assets remained nearly constant at EUR 84.1 m as of December 31, 2011. This compared with EUR 83.6 m (September 30, 2011). In the reporting period, Analytik Jena reported equity of EUR 39.8 m (September 30, 2011: EUR 38.6 m), representing an increase of 3.1 % and a rise in the equity ratio from 46.1 % as of September 30, 2011 to 47.3 % as of December 31, 2011. Cash and cash equivalents totaled EUR 6.0 m as of the end of the reporting period (September 30, 2011: EUR 5.5 m). This corresponds to a year-on-year increase of 9.1 % and is primarily the result of the 33.4 % rise in operating cashflow (EUR 1.7 m after three months, previous year: EUR 1.3 m).

Human Resources

As of the balance sheet date December 31, 2011, the Group employed 807 staff, including 39 trainees (previous year: 799 employees, including 46 trainees).

Outlook

For the rest of the financial year, Analytik Jena anticipates that the conditions affecting its business activities will remain largely the same. The Company expects to achieve profitable cross-segment growth with its entire portfolio in the current financial year 2011/2012.

For the second quarter, the Company anticipates sales will remain stable and results to be good.

As usual, Analytik Jena will announce its outlook for the entire financial year at the Annual General Meeting on April 24, 2012.

Further Information

The full financial report can be accessed at http://berichte.analytik-jena.de/3-MonthReport_1112.pdf.